Related Experiment Videos
Noncardioplegic surgery for ischemic mitral regurgitation
Kazuhito Imanaka1, Shunei Kyo, Masanori Ogiwara
1Department of Cardiovascular Surgery, Saitama Medical School, Japan. imanaka@saitama-med.ac.jp
Summary
This study demonstrates that non-cardioplegic surgery for ischemic mitral regurgitation (MR) is a safe and effective alternative, even in complex cases. The procedure, performed under ventricular fibrillation (VF), showed acceptable mortality and morbidity rates.
Area of Science:
- Cardiovascular Surgery
- Cardiac Surgery
- Heart Valve Repair and Replacement
Background:
- Ischemic mitral regurgitation (MR) presents significant surgical challenges, particularly in patients with reduced ejection fraction (EF).
- Traditional surgical approaches may be limited in specific patient populations, necessitating alternative techniques.
Purpose of the Study:
- To evaluate the safety and efficacy of non-cardioplegic surgery for ischemic MR.
- To assess clinical outcomes, including mortality and morbidity, in patients undergoing this procedure.
Main Methods:
- Twenty-seven patients with ischemic MR underwent surgery involving coronary artery bypass grafting (CABG) followed by mitral valve repair or replacement.
- The procedure was performed under ventricular fibrillation (VF) with intermittent aortic cross-clamping and moderate hypothermia.
- The mitral procedure was conducted via a right-sided left atriotomy, with the heart perfused through native coronary arteries and CABG grafts.
Main Results:
- Hospital mortality was 3.7% (1 death in 27 patients).
- Mean ejection fraction (EF) improved from less than 30% preoperatively to 48% at hospital discharge.
- Low rates of prolonged intra-aortic balloon pump (IABP) support and mechanical ventilation were observed.
Conclusions:
- Non-cardioplegic surgery for ischemic MR is associated with acceptable mortality and morbidity.
- This technique offers a viable alternative, particularly when aortic clamping is undesirable.
- Extended periods of ventricular fibrillation did not correlate with adverse clinical outcomes.